But the agency said later it was re-evaluating the decision that the shortage is over amid litigation, putting compounding of ...

The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versi ...

U.S. Customs and Border Protection officers in Cincinnati recently seized more shipments containing unapproved medications.

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the ...

Semaglutide belongs to the class of drugs called Glucagon ... Mounjaro/Zepbound (active ingredient - tirzepatide) for import ...

Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

When starting prescription weight loss medications, getting approval from a doctor and insurance is one of the hardest parts.

Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide ...

With a positive readout for metabolic dysfunction-associated steatohepatitis (MASH) now in the bag, Novo Nordisk is gearing ...

Like semaglutide, this is one of the diabetes drugs for weight loss that’s injected once weekly. Tirzepatide is the active ingredient in the brand-name drugs Mounjaro® and Zepbound®.

With the FDA approval of the first specific drug for Metabolic Associated Steatohepatitis (MASH) in March this year, Madrigal’s Rezdiffra is a pioneer in a market set for rapid change. | With the FDA ...